Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...
The study analyzed some 5,000 young females – and found a dramatic reduction in key strains of...
The aftermath of a catastrophic clinical trial in France has raised concerns regarding the lack...
It is ill-advised to take large quantities of these vitamins over long periods of time. Read...
In recent years, there has been a resurgence in the number of Alzheimer’s disease (AD) clinical trials, led by major efforts from Biogen, Lilly, Genentech/Roche, and others. With the first of these novel AD therapies potentially coming to market as early as 2017/2018, there are a number of critical and as yet unanswered questions surrounding the economics and policy of AD diagnostic screening.
In recent years, researchers have made considerable headway in efforts to improve both the pharmacokinetics and safety of therapies based on rIL-12 based on the use of more advanced delivery mechanisms.
Many novel drugs are set to lose their patents by 2020, meaning South Korea’s generics market is expected to increase significantly.
Vaccinations for three different influenza strains were given to an approximate 276 adults, over the age of 65.
Google’s Calico, an institution with a mysterious mission to “cure death” could have competition from a new collaboration between Ascentage Pharma and Unity Biotechnology.
Over the course of 12 weeks, patients were administered either Chantix or Zyban, a nicotine patch, or a placebo followed by an additional 12 weeks of follow-up.
The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.
The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.
This disease marks the third treatment indication GW is pursuing.
Vice President Joe Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data in an effort to accelerate ambitious cancer research goals, at the American Association for Cancer Research annual meeting.
Immuno-oncology products have demonstrated comparable respective efficacy and safety profiles.
These results bode well for individuals suffering from this disease.
Scientists discovered this over-the-counter drug could have special properties.
Stanford, Memorial Sloan Kettering Cancer Center, and the University of Pennsylvania are some of the institutions taking part in this endeavor.
In the new frontier of precision medicine, today’s explorers do not emulate Ferdinand Magellan, Vasco da Gama, John Smith, or Neil Armstrong, wielding armor and protective gear to combat attackers or the elements.